This presentation focuses on how medical device manufacturers should meet ISO 10993 requirements addressing biological risk and performance, in the context of EU and FDA regulatory submissions.
By looking at the history of medical device regulation we understand how regulatory agencies think today, and by sharing case studies of common mistakes and pitfalls, we learn how to develop a smooth path to regulatory approval.